BioCentury
ARTICLE | Clinical News

CDX-1401: Additional Phase I data

November 12, 2012 8:00 AM UTC

Celldex expects the Cancer Immunotherapy Trials Network (CITN) to begin a trial of CDX-1401 next year, but the company said that the indication and trial design are yet to be determined. The National...